Non-invasive Imaging in the Pharmaceutical Industry
Book chapter, 2017
The pharmaceutical industry faces an existential threat. Over recent years, the time and costs to get a new drug to market have increased to unsustainable levels whilst productivity is declining. It is critical to both improve efficiency of the drug discovery and development process and to increase success rates, with better predictivity from preclinical to clinical investigation (Kola 2008). Imaging provides unique tools to improve efficiency, predictivity and probability of success.
Clinical investigation
Non-invasive imaging
Pharmaceutical industry
Probability of success
Development process
Predictivity
Drug discovery process
Drug development
Author
Sally Ann Emmas
AstraZeneca AB
Alderley Imaging Ltd
Paul Hockings
Chalmers, Signals and Systems, Signal Processing and Biomedical Engineering
Antaros Medical AB
John C Waterton
Alderley Imaging Ltd
University of Manchester
Small Animal Imaging
33-46
9783319422008 (ISBN)
Subject Categories (SSIF 2025)
Medical Biotechnology
DOI
10.1007/978-3-319-42202-2_2